Latest filing published 03 Jun 2025 for Neogenomics INC.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +10.2%Entry US$8.13 · Close at T+365 US$8.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Neil Gunn: trading record in brief
Neil Gunn discloses dealings in Neogenomics Inc to SEC (Form 4). The record holds 3 filings, for trades running from 10 August 2024 to 1 June 2025.
Purchases make up the whole of the open-market record (1 purchase, €31k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. 2025 to date brings 1 purchase and no sales.
The record was last updated on 3 June 2025 with an option exercise in Neogenomics Inc. The last insider purchase was made public on 7 May 2025, 552 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Neil Gunn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,254 shares0Common StockSEC:0001077183-25-000124:0
- 4,510.31 shares@ US$7.755100.0% of flowCommon StockSEC:0001077183-25-000093:0Canonical exit: 3 Aug 2025 (T+90)
- 11,336 shares0Common StockSEC:0001077183-24-000124:0
3 of 3 declarations
